Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580. (International Journal of Radiation Oncology, Biology, Physics (2023) 117(3) (571–580), (S0360301623004388), (10.1016/j.ijrobp.2023.04.030))
Other Scholarly Work
Gondi, V, Deshmukh, S, Brown, PD et al. (2025). Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580. (International Journal of Radiation Oncology, Biology, Physics (2023) 117(3) (571–580), (S0360301623004388), (10.1016/j.ijrobp.2023.04.030))
. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 121(2), 571-572. 10.1016/j.ijrobp.2024.08.041
Gondi, V, Deshmukh, S, Brown, PD et al. (2025). Erratum to: Gondi V, Deshmukh S, Brown PD, et al. Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms With Hippocampal Avoidance During Whole-Brain Radiation Therapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys. 2023;117:571-580. (International Journal of Radiation Oncology, Biology, Physics (2023) 117(3) (571–580), (S0360301623004388), (10.1016/j.ijrobp.2023.04.030))
. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 121(2), 571-572. 10.1016/j.ijrobp.2024.08.041
The title for Figure 3 is corrected. The authors regret the following 2 errors in the above-noted article. 1. Under “Primary analysis and cognitive outcomes, the 95% CI and corresponding should value should be 0.59-0.97, P = .00249 and in the third sentence, the corrected HR, 95% CI, and P value are as follows: HR = 0.64; 95% CI, 0.49-0.85; P = .002.” 2. In “Correlation between baseline cognitive function and patient-reported psychological distress,” there was an error in the programming. The Results and Discussion are revised below: Increased patient-reported anxiety/depression at 6 months was associated with lower baseline scores in Delayed Recall (ρ = −0.25, P = .0019) and Delayed Recognition (ρ = −0.17, P = .042; Table A9). Increased patient-reported anxiety/depression at 6 months was also associated with lower baseline TMT-A scores (ρ = −0.19, P = .02), poorer baseline performance on TMT-B (ρ = −0.28, P < .001; Table A9) and worse CTB composite score (ρ = −0.23, P = .004; Table A9). Improved mood at 6 months was associated with lower baseline scores in HVLT-R Delayed Recall (ρ = −0.19, P = .020). Increased feelings of being sad at 6 months was associated with poorer baseline performance on Delayed Recognition (ρ = −0.17, P = .040; Table A10). As exploratory findings, poorer cognitive performance at baseline (ie, prior to study treatment) was associated with greater subsequent patient-reported anxiety/depression. The strongest correlations (ρ of 0.25-0.28) occurred between poorer learning and memory and executive function at baseline, and greater patient-reported anxiety and depression at 6 months.
